| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.64▼ | 1.64▼ | 1.64▼ | 1.63▼ | 1.48▲ |
| MA10 | 1.64▼ | 1.64▼ | 1.63▼ | 1.53▲ | 1.51▲ |
| MA20 | 1.64▼ | 1.64▼ | 1.66▼ | 1.49▲ | 1.69▼ |
| MA50 | 1.64▼ | 1.65▼ | 1.59▲ | 1.52▲ | 3.02▼ |
| MA100 | 1.66▼ | 1.57▲ | 1.49▲ | 1.78▼ | 3.57▼ |
| MA200 | 1.63▼ | 1.49▲ | 1.48▲ | 2.95▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.001▼ | -0.008▼ | 0.032▲ | 0.074▲ |
| RSI | 41.822▼ | 45.387▼ | 49.348▼ | 57.034▲ | 38.499▼ |
| STOCH | 36.984 | 53.704 | 37.500 | 66.152 | 41.039 |
| WILL %R | -77.778▼ | -77.778▼ | -84.615▼ | -33.670 | -29.078 |
| CCI | -223.810▼ | -62.080 | -65.185 | 77.963 | 124.365▲ |
| ▲ MACD | $DCGO MACD(12,26,9) Crossed Above Zero | Set Alert |
|
Saturday, August 09, 2025 07:19 AM
Looking ahead, revenue is expected to decline by 9.5% p.a. on average during the next 3 years, while revenues in the Healthcare industry in the US are expected to grow by 5.9%.
|
|
Friday, August 08, 2025 02:54 AM
DocGo Inc. reveals strong Q2 2025 performance with rising cash flow, cost savings, tech advancements, and new contracts.
|
|
Friday, August 08, 2025 01:16 AM
Despite a significant revenue decline, DocGo Inc (DCGO) showcases operational efficiency and strategic expansions in Q2 2025.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 1.65 | 1.66 | 1.605 | 1.62 | 956,426 |
| 14/08/25 | 1.70 | 1.70 | 1.61 | 1.63 | 391,757 |
| 13/08/25 | 1.68 | 1.7594 | 1.65 | 1.73 | 888,421 |
| 12/08/25 | 1.55 | 1.67 | 1.53 | 1.66 | 564,871 |
| 11/08/25 | 1.57 | 1.60 | 1.50 | 1.53 | 476,338 |
| 08/08/25 | 1.54 | 1.7799 | 1.50 | 1.57 | 1,296,758 |
| 07/08/25 | 1.39 | 1.49 | 1.37 | 1.39 | 630,916 |
| 06/08/25 | 1.45 | 1.45 | 1.40 | 1.41 | 408,264 |
| 05/08/25 | 1.42 | 1.42 | 1.35 | 1.40 | 398,463 |
| 04/08/25 | 1.33 | 1.40 | 1.33 | 1.40 | 374,029 |
|
|
||||
|
|
||||
|
|